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 Θα ήζεια λα θαηαζέζσ ηηο νιόζεξκεο επραξηζηίεο κνπ ζην Γηεπζπληή 
ηνπ ΠΜ΢ Καζεγεηή Ζιία Εηληδαξά ν νπνίνο θαηάθεξε κε ηελ επηζηεκνληθή ηνπ 
νκάδα λα νξγαλώζεη έλα ελδηαθέξνλ, ρξήζηκν γηα πνιιέο επηζηήκεο θαη πνιπ 
πςεινύ επηπέδνπ κεηαπηπρηαθό: “ΜΔΘΟΓΟΛΟΓΗΑ ΒΗΟΗΑΣΡΗΚΖ΢ ΔΡΔΤΝΑ΢, 
ΒΗΟ΢ΣΑΣΗ΢ΣΗΚΖ ΚΑΗ ΚΛΗΝΗΚΖ ΠΛΖΡΟΦΟΡΗΚΖ”. Δπίζεο ηνλ επραξηζηώ απν 
θαξδηάο γηαηί ήηαλ ν άλζξσπνο πνπ κε θαζνδήγεζε έμππλα ζηε ζπγγξαθή ηεο 
δηπισκαηηθήο εξγαζίαο θαη κνπ θαλέξσζε πνιιά κπζηηθά ηεο Βηνζηαηηζηηθήο 
Δπηζηήκεο.  Δπίζεο ζα εζεια λα επραξηζηήζσ νιόςπρα ηα κέιε ηεο 
ηξηκεινύο επηηξνπήο γαη ηε Γηπισκαηηθή κνπ Δξγαζία Καζεγεηή Νεθξνινγίαο 
– Πξόεδξν ηνπ Ηαηξηθνύ Σκήκαηνο Παλεπηζηεκίνπ Θεζζαιίαο Ησάλλε 
΢ηεθαλίδε θαη ηελ θ, Υξπζνπια Γνμάλε, Ηαηξό, Δπηζηεκνληθή ζπλεξγάηεο ηνπ 
ηκήκαηνο Βηνζηαηηζηηθήο πνπ αγόγγπζηα κνπ παξείραλ ηηο ζπκβνπιέο ηνπο . 
 Σέινο δελ ζα κπνξνύζα λα κελ επραξηζηήζσ όιε ηελ νηθνγέλεηά κνπ 
(δηαίηαξα ηε ΢ύδπγν Μαίξε Ρνύθα θαη ηα παηδηά κνπ Γηώξγν θαη Μηράιε ) πνπ 
κε αλέρηεθαλ θαη κε ελζάξξπλαλ θαηά ηε δηάξθεηα απηνύ ηνπ κεηαπηπρηαθνύ 
πξνγξάκκαηνο. 
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Abstract 
Background: Peripheral Arterial Disease (PAD) is a complex disease with 
genetic background. The genetic association studies (GAS) that investigated 
the association between PAD and the MTHFR C677T gene variant have 
produced contradictory or inconclusive results.  
Materials and Methods: In order to decrease the uncertainty of estimated 
genetic risk effects and to explore whether there is enough evidence to claim 
or deny association between the variant and PAD, a meticulous meta-analysis, 
including cumulative and recursive cumulative meta-analyses, of all relevant 
published GAS was conducted. The risk effects were estimated based on the 
generalized odds ratio (ORG), a genetic model-free approach.  
Results: The analysis showed large heterogeneity studies (I2=57%, PQ<0.01) 
and marginal significant association for the MTHFR C677T variant [ORG=1.21 
(1.01-1.48)]. However, a sensitivity analysis for the studies with the controls not 
in Hardy-Weinberg equilibrium derived a significant association [RE ORG=1.26 
(1.09-1.45)]. The cumulative meta-analysis indicated a trend of association as 
evidence accumulates and the recursive cumulative meta-analysis indicated 
lack of sufficient evidence for claiming or denying an association.  
Conclusion: The current evidence is not sufficient to draw definite conclusions 
regarding the association of MTHFR variants and development of PAD. More 
studies are needed to be conducted.  
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1. Introduction 
Peripheral arterial disease (PAD) encompasses a large series of 
noncoronary arterial syndromes and affects approximately 20% of adults older 
than 55 years and an estimated 27 million persons in North America and 
Europe (1). The term “peripheral arterial disease” includes a diverse group of 
disorders that lead to progressive stenosis or occlusion, or aneurismal dilation, 
of the aorta and its noncoronary branch arteries, including the carotid, upper 
extremity, visceral and lower extremity arterial branches (2). About one fifth of 
people with lower extremity PAD have typical symptoms of intermittent lower 
limb claudication, “rest pain”, ulceration, or gangrene, another third have 
atypical exertional leg symptoms whereas half of all people are 
asymptomatic(3). 
The existence of inherited genetic predisposition to PAD has been 
investigated with various types of familial aggregation studies (4-8). Heritability 
estimates have shown that the contribution of genetic factors to overall 
variation in ankle-brachial index, which is a widely utilized measure for 
detecting PAD, was 21% (8). One main approach to disentangle the genetic 
etiology of complex human traits includes association studies. Genetic 
association studies, in particular, are central to efforts to identify and 
characterize genomic variants (e.g. single nucleotide polymorphisms, SNPs) 
underlying susceptibility to PAD. Polymorphisms may influence gene activity 
and mRNA conformation, alter the protein binding ability to its substrate and 
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change its sub-cellular localization. Therefore, polymorphisms are emerging as 
possible factors that may predispose to PAD and correlate with the 
pathogenesis of the disease (9) 
Methylenetetrahydrofolate reductase (MTHFR) is a critical enzyme in 
one-carbon metabolism. MTHFR catalyzes the irreversible conversion of 5,10-
methylenetrahydrofolate to 5-methyltetrahydrofolate, which is the predominant 
circulating form of folate and serves as the carbon donor for the remethylation 
of homocysteine to methionine (10). The MTHFR (11, 12) gene is localized on 
chromosome 1p36.3. The common polymorphism (variant) have been 
described in the MTHFR gene is the C677T (exon 4 at codon 222) which are 
single nucleotide substitution resulting in amino acid changes, which is a C>T 
substitution at position 677 resulting in an alanine to valine substitution. The 
polymorphism has an impairment in the enzyme activity. The 677T allele has 
been found to result in decreased enzyme activity (11, 12) leading to increased 
homocysteine levels and thus to an imbalance in plasma folate concentration. 
The C677T polymorphism is implicated with the development of PAD and have 
already been associated with different disorders/diseases (13-16) . However, 
other functional polymorphisms in genes associated with impaired folate 
metabolism, may also contribute to the risk of cancer and other disorders (17, 18)  
The genetic association studies (GAS) that investigated the association 
between PAD and the MTHFR C677T variant have produced contradicted or 
inconclusive results, partly because the studies had limited sample sizes and 
their power was not adequate to demonstrate significant association. In 
addition, the studies involved different populations and sampling strategies 
making the interpretation of results difficult. Two meta-analyses(19,20)  regarding 
the role of MTHFR C677T variant has been previously carried out, but they 
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include relative scarce information available at that time and they did not focus 
on whether there is enough evidence to claim and deny association between 
the MTHFR C677T variant and PAD.  
In the present study, a meticulous meta-analysis(21), including 
cumulative and recursive cumulative meta-analysis (22, 23) , was performed for 
GAS related the MTHFR C677T variant with PAD. Aim of the meta-analysis 
was to provide an estimated pooled genetic risk effect with decreased 
uncertainty and to explore whether there is sufficient evidence to deny or claim 
association. The consistency of genetic effects across traditionally defined 
ethnicities was also examined.  
2. Material and Methods 
2.1. Identification and eligibility of relevant studies 
GAS that investigated the association of the MTHFR C677T genetic 
variant with the risk of developing PAD, published in English before August 
2015 were considered in the meta-analysis. The studies were identified by 
systematically searching the PubMed database. The following search criterion 
was used: ("peripheral arterial disease" OR "peripheral artery disease" OR 
"PAD" OR "peripheral arterial occlusive disease" OR "lower extremity arterial 
disease" OR "atherosclerotic vascular disease" OR "peripheral vascular 
disease" OR "intermittent claudication" OR "limb ischemia") AND 
(“methylenetetrahydrofolate reductase” or “MTHFR” or “C677T”) and 
(“association” or “risk” or “susceptibility”). Then, the abstracts were retrieved 
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and screened to assess their appropriateness for inclusion in the meta-
analysis. After the abstract screening, the articles were read in their entirety in 
order to assess their eligibility for the meta-analysis. Finally, all the references 
in the eligible articles were extensively reviewed to identify additional published 
articles not indexed by PubMed database.  
The eligible studies fulfilled the following inclusion criteria: 1) providing 
cases with clinically diagnosed PAD and healthy controls free of PAD,             
2) providing information on the genotype distribution of C677T variant in 
patients with PAD and in healthy controls subjects, 3) using DNA-based 
analysis methods for genotyping, and 4) including subjects who were human. 
In this article we focus on lower extremity PAD, which is a chronic obstructive 
disease of the aortic, iliac and lower limb arteries.(24) Cases were thus 
considered as patients suffering from lower extremity PAD, with the diagnosis 
based on noninvasive and invasive diagnostic tools. Studies investigating 
progression, severity, phenotype modification, response to treatment, or 
survival were excluded from our study. Case reports, editorials, and review 
articles were also excluded. Finally, family-based studies were excluded 
because of different design settings. 
 
2.2. Data extraction 
From each study the following information was extracted: first author, 
journal, year of publication, ethnicity of study population, demographics, 
diagnosis criteria for PAD and genotype distribution.  
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2.3. Data synthesis and analysis 
The meta-analysis examined the association between the MTHFR C677T 
variant and the risk of PAD based on the generalized odds ratio (ORG)
(25). The 
ORG provides an estimate of the overall risk effect by utilizing the complete 
genotype distribution. The ORG express the probability of a subject being with 
PAD relative to probability of being free of disease, given that the subject with 
PAD has a higher mutational load than the non-diseased.(25, 26) 
In synthesizing the studies, the fixed effects (FE) and random effects 
(RE) ORG were used.
(21, 25, 27) The RE model incorporates in the estimates the 
between study variability (21). The heterogeneity between studies was tested 
using the Q-statistic (28, 29) and the heterogeneity was considered significant at 
PQ<0.10. The heterogeneity was also quantified using the I
2 metric which takes 
values between 0% and 100% with higher values denoting greater degree of 
heterogeneity(30). When the heterogeneity is large and significant the RE model 
might be used whereas when there is lack of heterogeneity the RE model 
coincides with the FE effects model (31). In order to evaluate the trend of 
association, a cumulative and recursive cumulative meta-analysis was 
conducted based on the RE ORG (21, 23, 32). In cumulative meta-analysis, 
studies were chronologically ordered by publication year and the OR is 
obtained at the end of each year (each information step) (21). In recursive 
cumulative meta-analysis, the relative change in OR at each information step 
was calculated. Cumulative and recursive cumulative meta-analyses, provide 
the framework for updating the estimated genetic risk effect in time and they 
measure the changes in risk effect as evidence accumulates (21). In particular, 
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the cumulative meta-analysis indicates the trend in the risk effect and recursive 
cumulative meta-analysis indicates the stability in the risk effect. The 
differential magnitude of effect in large versus small studies for the allele 
contrast was checked using the Harbord’s test (33). 
The meta-analysis consisted of the overall analysis, which includes all 
available data and subgroup analysis by ethnicity (“racial” descent). A 
sensitivity analysis which examines the effect of excluding specific studies was 
also considered (21). The distribution of the genotypes in the control group was 
tested for conforming to the Hardy-Weinberg equilibrium (HWE) rule using an 
exact test (21). Deviation from HWE indicates possible genotyping errors and/or 
population stratification and studies with controls deviated from HWE were 
subjected to a sensitivity analysis (21). Analyses were performed using 
ORGGASMA (http://biomath.med.uth.gr) (25, 26). 
3. Results 
3.1. Eligible studies and studies’ characteristics 
The literature review identified 48 articles in PubMed that met the search 
criteria. Data from 12 articles met the inclusion criteria. Figure 1 presents a 
flow chart of the retrieved and excluded studies with specification of reasons. 
The characteristics of the individual studies included in the meta-analysis are 
provided in Table 1. The studies provided 1578 cases and 2580 controls. The 
studies were published between 1998 and 2011. The studies used validated 
genotyping methods for the determination of the genetic variants and the 
diagnosis of PAD was based on valid criteria. Studies were conducted in 
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various populations of different ethnicity: 10 involved Whites and two Brazilian 
populations. The distribution of genotypes in the control group deviated from 
HWE (P≥0.05) in four studies (34-37). Then, a sensitivity analysis was carried out 
for these studies.  
3.3. Meta-analysis results 
Figure 2 and Table 2 show the meta-analysis results for the association 
between the MTHFR C677T variant and the risk of developing PAD. The overall 
analysis for investigating the association between the variant and the risk of PAD 
showed a large heterogeneity between studies (I2=57%, PQ<0.01) and the risk of 
PAD on the basis of the current evidence was marginally significant was also 
showed for Whites [FE ORG=1.12 (1.01-1.26) and RE ORG=1.13 (0.94-1.34)].        
 3.4. Potential Bias 
None of the studies reported that genotyping was blinded to clinical 
status. The cumulative meta-analysis, revealed a trend of association as 
information accumulates in the studied period (1998-2011) with the association 
being significant at the end of this period Figure 3. The recursive cumulative 
meta-analysis showed that the relative change in ORG did not stabilize around 
OR=1, indicating that there is no sufficient evidence for claiming or denying 
association Figure 4. Thus, more studies should be conducted in order to 
provide conclusive evidence for the association between the variant and PAD. 
The test by Harbord et al. for C677T indicated that there is no differential 
magnitude of effect in large versus small studies (P=0.34).  
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4. Discussion 
Herein, we presented a comprehensive meta-analysis of GAS 
investigated the association between the MTHFR C677T variant and PAD 
susceptibility. The purpose of the meta-analysis was to provide an estimate of 
the genetic risk effect with a reduced uncertainty and to explore the trend of 
risk effect as evidence accumulates. The individual GAS included in the meta-
analysis have relatively small sample sizes to detect the minor contribution of 
the mutant alleles in PAD susceptibility. Typically, for a modest significant risk 
effect (OR around 1.3) to be detected in single GAS, a sample size of more 
than 10,000 subjects is needed to achieve power >80% (22). The meta-analysis 
has the advantage by synthesizing data from published GAS to provide greater 
power to detect significant associations than an individual GAS, especially in 
the absence of large heterogeneity between studies (21). However, there is no 
established methodology for calculating the power of the meta-analysis. In 
addition, meta-analysis is a retrospective all inclusive synthesis of published 
studies and power analysis may not be applicable (21). Nevertheless, type II 
errors are expected to be less in a meta-analysis than in the individual         
GAS (21).  
The association was assessed based on the ORG. The current practice 
is to analyse various genetic models, such as the dominant, recessive, additive 
and co-dominant models; however, these models are not independent (25). In 
addition, there is no a priori biological justification for choice of a specific 
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genetic model. The ORG is a metric that quantifies the probability of disease, 
given that a diseased subject has a higher, or lower, mutational load than a 
healthy one. The use of ORG is a genetic-model free approach and provides an 
integrated way to evaluate genetic associations, by exploiting all available 
information in terms of disease and genotype distribution (25). Thus, the 
application of ORG in analysis and meta-analysis of individual GAS may 
overcome the drawbacks of multiple model testing or erroneous model 
specification (25). 
Overall, only marginal association between the MTHFR C677T variant and 
risk of PAD was found in the meta-analysis. However, the sensitivity analysis for 
the studies with the controls not in HWE revealed a significant association. 
However, the heterogeneity between studies is large and therefore, the findings 
should be interpret with caution. Also, the meta-analysis indicated lack of 
differential magnitude of effect in large versus small studies (“publication bias”); 
however, inspection of funnel plot was avoided since its interpretation can be 
misleading (38). Nevertheless, the conclusions reached in the present meta-
analysis were based on relatively small numbers of studies and participants and 
thus, any inferences have to be cautious. The cumulative and the recursive 
cumulative meta-analyses indicated that there is a trend towards to association 
and that more evidence is needed to draw definite conclusion regarding the 
existence or absence of association for the MTHFR C677T variant.  
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Stratification in genetic association studies might blur the genetic effect. 
In the studies with the controls not conformed to HWE, the lack of HWE 
indicates population stratification and/or genotyping errors. Besides, deviation 
from HWE in a population implies continued selection, migration, mutation, and 
absence of random mating (39). Hence, the validity of the genotyping method 
and the selection of controls are questionable for these studies (39, 40). 
Moreover, the absence of reporting blindness to phenotype in genotyping 
laboratory personnel and the possible lack of a controlled genotyping 
procedure may potential bias which is difficult to assess.  
The lack of strong association between the MTHFR C677T variant and 
PAD might be due to other unidentified functional variants that exist in the 
folate pathway and the MTHFR gene that are in linkage disequilibrium, and 
therefore, they may affect the susceptibility to PAD. However, the development 
of PAD might be associated with gene-gene-environment interactions and their 
effects should be considered in individual GAS and subsequent meta-analyses 
(41). Currently, limited information is provided by the individual GAS and the 
available study-level genotype distribution was used in the meta-analysis, 
precluding the adjusted analysis for potential gene–gene–environment 
interactions (42). Thus, failure to account for these interactions may have 
reduced the efficiency of the genetic risk estimates, but is unlikely to inflate 
false-positive results.  
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In conclusion, a marginal association between for the MTHFR C677T 
variant and risk of PAD has been detected in the present data synthesis. 
However, the results should be interpreted with caution since there is no 
sufficient evidence for the current published individual GAS to claim or deny 
association. Considering that PAD is a complex disease with multifactorial 
etiology, the minor contributing pathogenetic role of the MTHFR variants, 
including C677T, may not be totally excluded. The results of rigorous GAS that 
take into account epistatic and gene-environment interactions may provide 
more conclusive evidence regarding the genetic susceptibility to ALL.  
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Table 1: Characteristics of the studies considered in the meta-analysis. 
Author, 
year 
Ethnicity No of 
cases 
No  
of 
controls 
M/F 
with 
PAD 
M/F 
Controls 
Age of 
cases/controls 
meanSD 
median  
(min-max) 
Diagnostic 
criteria for 
cases of PAD 
Fowkes,  
2000 
caucasian 80 300 41/39 144/156 65.9 (0.6)/ 
63.2 (0.3) 
ABPI was used 
in baseline 
studies and 
World Health 
Organization 
intermittent 
claudication 
questionnaire 
was used on 
follow-up 
Mueller,  
2005 
caucasian 433 433 306/1
27 
306/127 68 (59-75)/ 
68 (60-75) 
Clinical criteria 
were confirmed 
by ABPI and 
arteriography. 
Sofi,  
2005 
caucasian 280 280 216/6
4 
216/64 69 (35-90)/  
70 (33-95) 
Fontaine stage 
II to IV and 
confirmed by 
ABPI 
Sabino,  
2007 
mixed 
(brazilian) 
44 37 26/18 17/20 68.9±9.7/ 
60.9±9.2 
clinical 
examination 
and 
measurement 
of the 
ankle/arm 
index 
Jones,  
2005 
caucasian 226 282 131/9
5 
120/162 71.6±9.1/ 
69.5±7.60 
Clinical criteria 
were confirmed 
by ABPI and 
arteriography. 
Todesco,  caucasian 63 106 29/34 58/48 74±10/ (Fontaine, stage 
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1999 76±16 II and III/IV). 
Verhoef,  
1998 
caucasian 48 272 ND ND NR Clinical criteria 
confirmed by 
angiography 
and ultrasound. 
Rassoul,  
2000 
caucasian 85 51 85/0 51/0 60 ±11 (all) All patients 
were Fontaine 
stage III and IV 
Ciccarone,  
2003 
caucasian 130 212 99/36 155/64 65±8/ 
64±10 
Clinical criteria 
confirmed by 
ultrasound. DM 
II patients 
Pollex,  
2005 
caucasian 20 118  7/13 42/76 48 ±11.2/ 
45.8±11.7 
ABPI was used 
and World 
Health 
Organization 
intermittent 
claudication 
questionnaire. 
DM II patients 
Folclaud,  
2008 
caucasian 130 457 90/40 457/0 69.7±8/ 
60 (40-80) 
Patients with 
intermittent 
claudication 
and arterial 
insufficiency 
were confirmed 
by ABPI 
Santos,  
2011 
brazilian 39 32 23/16  9/23 66.89 ± 8.82/  
62.22± 12.92 
Clinical 
examination 
and 
measurement 
of ABI 
M: male, F: female, NR: not reported 
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Table 2: Fixed effects (FE) and random effects (RE) generalized odds ratios 
(ORG) and heterogeneity results (I
2, PQ-value) for the MTHFR C677T variant 
for testing its the association with PAD. 
Population Studies FE ORG (95% CI) I
2
, PQ-value
 
RE ORG (95% CI) 
All 12 1.15 (1.03-1.30) 57%, <0.01 
1.21 (1.01-1.48) 
All in HWE 8 1.26 (1.09-1.45) 59%, 0.02 
1.44 (1.11-1.87) 
Whites 10 1.12 (1.01-1.26) 46%, 0.06 
1.13 (0.94-1.34) 
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Figure 1: Flow chart of retrieved studies and studies excluded, with 
specification of reasons. 
 
 
 
 
 
 
 
 
 
 
48 retrieved articles 
5 in non-humans 
10 reviews or meta-analyses 
30 potentially relevant 
articles based on abstracts 
12 articles included in 
the analysis 
16 non-relevant articles   
2 with non-extractable data 
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Figure 2: Fixed effects (FE) and random effects (RE) odds ratio (OR) 
estimates with the corresponding 95% confidence interval (CI) for the ORG of 
MTHFR C677T variant and the risk of PAD. The horizontal axis is plotted on a 
log scale 
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Figure 3: Cumulative meta-analysis for MTHFR C677T variant in PAD: the 
pooled odds ratio (OR) with the corresponding 95% confidence interval (CI) at 
the end of each year-information step is shown 
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Figure 4: Recursive cumulative meta-analysis for MTHFR C677T variant in 
PAD: the relative change in random effects pooled odds ratio (OR) in each 
information step (OR in next year/ OR in current year) is shown. 
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